Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 1602  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (1,137 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 » Patients and Methods
 » Methodology
 » Results
 » Discussion
 » Conclusion
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    Viewed150    
    Printed0    
    Emailed0    
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
ORIGINAL ARTICLE
Year : 2019  |  Volume : 67  |  Issue : 4  |  Page : 1006-1012

The Correlation of Endothelial Nitric Oxide Synthase (eNOS) Polymorphism and Other Risk Factors with Aneurysmal Subarachnoid Hemorrhage: A Case-Control Study


1 Department of Neurosurgery, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
2 Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India

Date of Web Publication10-Sep-2019

Correspondence Address:
Dr. B Indira Devi
Department of Neurosurgery, National Institute of Mental Health and Neurosciences, Bengaluru - 560 029, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.266231

Rights and Permissions

 » Abstract 


Objective: Endothelial nitric oxide synthase gene (eNOS) polymorphism is an association with cerebral aneurysm formation, rupture, and vasospasm and plays a role in the a functional outcome.
Patients and Methods: The aim of the study was to evaluate the role of eNOS gene polymorphism and further assess the predictors of outcome in the aneurysmal subarachnoid hemorrhage (aSAH). A prospective case-control study was conducted from 2009 to 2012 among those who presented with aSAH. A serum sample was collected from aSAH patients along with age and sex-matched healthy controls. The frequency of polymorphism of eNOS gene and other factors (demographic and aneurysmal) were correlated with functional outcome at six month of follow-up.
Results: 100 patients with aSAH and 100 healthy controls were enrolled in the cohort. The mean age of the patient group was 51.61 years and control group was 45.81 years with a male:female ratio of 1:1.38 and 1:1.08 for patients and controls, respectively. Among all eNOS polymorphisms, 4BB (65%) 24-VNTR, TT (71%) of T-786C, and GG (71%) of G947T were the most common and frequency was similar in the control group. The occurrences of hypertension, smoking, diabetes were 32%, 37%, and 7% respectively in the patient group. Maximum patients were in WFNS grade 1 (53%) followed by 23% grade 2 and only 10% in grade 4. Fisher grade 3 (57%) was the most common followed by Fisher grade 4 (28%). Most aneurysms (97%) were in anterior circulation. 83% of the aneurysms were clipped and 10% underwent coiling. Size-wise most of the aneurysms were in the middle group (6–9 mm) followed by bigger group (>10 mm) (37%); only 6% aneurysms were in the small aneurysm (<6 mm) group. 33% of the patients had evidence of vasospasm. TT of G894T polymorphism (60%) had the highest incidence of vasospasm. Univariate analysis showed smoking (OR: 3.19, CI: 1.19–8.84, P = 0.01), 4AA (OR: 12.15, CI: 1.13–624.9, P = 0.03) variety of 24-VNTR polymorphism, CC (OR: 15.39, CI: 1.60–762.8, P = 0.01) variety of T786C polymorphism, Fisher grade 4 (OR: 3.43, CI: 1.24–9.68, P = 0.01), WFNS grade (poor vs. good) (OR: 3.42, CI: 1.17–10.12, P = 0.02), vasospasm (OR: 3.84, CI: 1.42–10.75, P = 0.006), intraoperative rupture (OR: 4.77, CI: 1.55–15.27, P = 0.004) were significantly related with unfavorable outcome at 6 months follow-up. In regression analysis, smoking (CI: 0.06–0.69, P = 0.01), Fisher grade 4 (CI: 0.09–1.00, P = 0.05), and intraoperative rupture (CI: 0.05–0.89, P = 0.03) were correlated with an unfavorable outcome at 6 months follow-up.
Conclusion: The eNOS gene polymorphism, smoking, clinical grade (WFNS), Fisher grade, intraoperative rupture, and vasospasm play a role in functional outcome after the treatment of cerebral aneurysms.


Keywords: Aneurysm, endothelial nitric oxide synthase gene, outcome, subarachnoid hemorrhage
Key Message: eNOS plays an important role in the formation, rupture and outcomes associated with Cerebral anuerysms. Our study provides valuable insights on the eNOS polymorphysm and its impact on 6 months outcomes in terms of complications associated with the intracranial aneurysms.


How to cite this article:
Konar SK, Ramesh S, Christopher R, Prasanthi A, Bhat DI, Shukla D, Bharath R, Devi B I. The Correlation of Endothelial Nitric Oxide Synthase (eNOS) Polymorphism and Other Risk Factors with Aneurysmal Subarachnoid Hemorrhage: A Case-Control Study. Neurol India 2019;67:1006-12

How to cite this URL:
Konar SK, Ramesh S, Christopher R, Prasanthi A, Bhat DI, Shukla D, Bharath R, Devi B I. The Correlation of Endothelial Nitric Oxide Synthase (eNOS) Polymorphism and Other Risk Factors with Aneurysmal Subarachnoid Hemorrhage: A Case-Control Study. Neurol India [serial online] 2019 [cited 2019 Sep 22];67:1006-12. Available from: http://www.neurologyindia.com/text.asp?2019/67/4/1006/266231




Aneurysm formation, rupture, and subsequent outcomes are due to multifactorial processes various modifiable and nonmodifiable risk factors are involved. Despite extensive attempts to identify the risk factors and the pathophysiology related to aneurysm formation, rupture, there has been limited success. Several genes have been analyzed in relation with aneurysm pathobiology.[1],[2],[3],[4] A study in the North American population analyzed the role of three eNOS gene polymorphisms as potential risk factors that can predict susceptibility to aneurysmal subarachnoid hemorrhage (aSAH) and cerebral vasospasm.[5] The exact role of eNOS gene and its polymorphism as a predictive factor has not been reported. However, evidence showed that the polymorphism of T-786C SNP variant reduced the eNOS gene promoter activation. Even the polymorphism of 27VNTR and T-786C variant produced decreased eNOS protein expression and enzymatic activity.[6]

The purpose of this study was to evaluate the role of eNOS gene polymorphism in the clinical course of aSAH and investigate the predictive factors determining the outcome of aSAH.


 » Patients and Methods Top


This was a prospective, case-control study conducted at the National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore. The study protocol was submitted for review by the Institute Human Ethics Committee and approval obtained prior to starting the study. Informed consent was taken from cases and controls before taking blood samples.

Case group

The study was carried out from December 2008 to July 2012 in NIMHANS, Bangalore. 100 patients diagnosed with SAH due to a cerebral aneurysm were included in the study. Patients with other vascular malformations (AVM, venous angioma, and congenital venous anomaly, dural arteriovenous fistula, cavernous angioma), recent onset myocardial infarction, intracranial mass lesion, and coagulation disorder were excluded from the study.

Control group

Gender-matched healthy subjects of similar age without a previous history suggestive of SAH were recruited by the Institute staff. Volunteers were recruited as controls. Demographic details along with past medical and family history were obtained. The subjects were examined in detail to rule out neurological deficits.


 » Methodology Top


Sample collection and DNA isolation

Six milliliters of blood were collected from the subjects in tubes containing EDTA. Genomic DNA was isolated from EDTA blood according to the conventional phenol–chloroform method. DNA was quantified using Nano Drop 1000 (Thermo Fisher Scientific, DE 19810, USA).

Genotyping

eNOS 4a/4b polymorphism screening

Genomic DNA was amplified using PCR (primers 5'-AGG CCC TAT GGT AGT GCC TTT-3' (sense) and 5'-TCT CTT AGT GCT GTG GTC AC-3' (antisense) with Taq DNA Polymerase (Solis BioDyne, Estonia) and supplied buffer under the following conditions: 95°C for 5 min, followed by 35 cycles at 94°C for 30 s, 59°C for 45 s, and 72°C for 45 s, followed by a 10-min 72°C final extension. PCR products were electrophoretically separated on a 2% agarose gel. The 4/4 homozygous 4a allele (containing 4 of 27 bp repeats) gave rise to PCR product of 393 bp, the 5/5 homozygous 4b allele (containing 5 of 27 bp repeats) gave rise to PCR product of 420 bp whereas the 4/5 heterozygous 4ab allele gave rise to 420 and 393 bp bands [Figure 1].
Figure 1: Representative band patterns for the eNOS 4ab genotype. (a) Characteristic PCR bands of 393 and 420 bp of representative individuals with homozygous 4a (a, lanes 1, 2) and 4b (b, lanes 1, 2, 6) or heterozygous 4ab (lanes 3–5) genotypes. Marker: pUC19 DNA/MspI (HpaII)

Click here to view


eNOS–786T>C polymorphism screening

Genomic DNA was amplified using PCR (primers 5'-GTG TAC CCC ACC TGC ATT CT-3' (sense) and 5'-CCC AGC AAG GAT GTA GTG AC-3' (antisense) with Taq DNA Polymerase (Solis BioDyne, Estonia) and supplied buffer under the following conditions: 95°C for 5 min, followed by 35 cycles at 94°C for 30 s, 63°C for 45 seconds, and 72°C for 45 seconds, followed by a 10-min 72°C final extension. PCR products of 308 bp were then digested with the restriction enzyme NaeI (New England Biolabs, Ipswich, Massachusetts, United States) at 37°C for 16 h and were electrophoretically separated on a 2% agarose gel. The -786 C allele is characterized by diagnostic NaeI restriction fragments of 227 and 81 bp. Thus, the gel pattern for individuals with homozygous mutant genotype (-786CC) showed 227 and 81 bp bands whereas -786 TT homozygous wild type did not undergo digestion by NaeI and showed PCR band of 308 bp. Individuals with -786 TC heterozygous genotype showed both intact PCR band of 308 bp and two cleaved bands of 227 and 81 bp [Figure 2].
Figure 2: Representative band patterns for the eNOS -786 T>C genotype. (a) Characteristic PCR bands of 308 bp product. (b) RFLP analysis of representative individuals with homozygous or heterozygous genotypes. Marker: pUC Mix Marker, 8, ready to use

Click here to view


eNOS 894G>T polymorphism screening

Extracted DNA was amplified using PCR (sense primer 5'-AAG GCA GGA GAC AGT GGA TGG A-3'; anti-sense primer 5'-CCC AGT CAA TCC CTT TGG TGC TCA-3') with Taq DNA Polymerase (Solis BioDyne, Estonia) and supplied buffer under the following conditions: 95°C for 5 min, followed by 35 cycles at 94°C for 30 seconds, 67.5°C for 45 s, and 72°C for 45 seconds, followed by a 10-min 72°C final extension. PCR products of 248 bp were then digested with restriction enzyme Dpn II (New England Biolabs, Ipswich, Massachusetts, United States) at 37°C for 16 h and were electrophoretically separated on a 2% agarose gel. The 894T allele is characterized by diagnostic Dpn II restriction fragments of 163 and 85 bp. Thus, the gel pattern for individuals with homozygous mutant genotype (894 TT) showed 163 and 85 bp bands whereas 894 GG homozygous wild type did not undergo digestion by Dpn II and showed PCR band of 248 bp. Individuals with 894 GT heterozygous genotype showed both intact PCR band of 248 bp and two cleaved bands of 163 and 85 bp [Figure 3].
Figure 3: Representative band patterns for the eNOS 894 G>T genotype. (a) Characteristic PCR bands of 248 bp product. (b) RFLP analysis of representative individuals with homozygous or heterozygous genotypes. Marker: pUC Mix Marker, 8, ready to use

Click here to view


Outcome scale

Glasgow outcome scale (GOS) was used to quantify the functional outcome. The primary goal was to assess the functional outcome at 6 months follow-up. The detail of GOS (5 = good recovery—able to return to work; 4 = moderate disability—able to live independently; unable to return to work; 3 = severe disability—able to follow commands/unable to live independently; 2 = vegetative state; 1 = dead).

Statistical analysis

Demographic data (patient related) and aneurysm-related data were categorized to determine predictive factors controlling the outcome. Chi-square test, univariate analysis were applied for analysis of individual factors. Later, regression analysis was done to finalize the predictive factors related to unfavorable outcome. Analyses were performed utilizing the SPSS software (v21, IBM Inc., Armonk, NY). P < 0.05 was considered statistically significant.


 » Results Top


A total of 100 patients were included in the test group and 100 volunteers were included in the control group. Age of the aSAH patients ranged from 18 to 75 years, with a mean age of 51.61 years. Only one patient was 18 years and the polymorphism status was positive for 4BB, TT (T-786-C), and GT (G894T). The controls were in the range of 24–71 years, with the mean age being 45.81 years. Among the cases, 42 were males and 58 were females. Among the controls, 48 were males and 52 were females. Four cases had a family history of SAH though further details are not known. Among them, three cases were 4BB positive and one case was 4AB positive, all four were positive for TT (T-786-C) and three cases were positive for GG (G894T).

Three different eNOS polymorphisms were analyzed from each blood sample. The most frequent 24-VNTR polymorphism types were 4BB (65%) followed by 4AB (30%) and 4AA (5%). The frequency was almost similar in the control group. TT (71%) was the frequent T-786-C polymorphism followed by TC (23%) and CC (6%). Among the G894T polymorphism, GG (71%) most frequent followed by GT (23%) and TT (6%). No significant differences in the distribution of allele and genotype frequencies in the patients and control groups were observed. Allele frequency distributions in controls and patient populations were found to be in Hardy–Weinberg equilibrium [Table 1].
Table 1: Demographic details and eNOS polymorphism

Click here to view


The clinical presentations of aSAH cases are shown [Table 2]. The incidences of comorbidities were as follows: 32% patients with hypertension, 37% with a history of smoking, and 9% with diabetes. The usual presentation was sudden onset headache (96%) followed by loss of consciousness (64%). 17% of patients patients presented with seizures at the onset.
Table 2: Clinical features and aneurysm details

Click here to view


53% of patients were patients were in WFNS grade 1, 23% grade 2, 11% grade 3, and 10% were in grade 4. According to Fisher's grading, most of the patients were in grade 3 (57%) followed by grade 4 (28%). The most common location was anterior circulation (97%) followed by the posterior circulation (3%). Among 100 aneurysms, 83% aneurysms were clipped and 10% underwent coiling. Most of the aneurysms were in the middle group (6–9 mm) followed by bigger group (>10 mm) (37%) and only 6% aneurysms were in a small aneurysm (<6 mm) group. 33% of patient patients had evidence of vasospasm (angiographic) and those who developed clinical symptoms received treatment for vasospasm. TT of G894T polymorphisms had the highest occurrence (60%) of vasospasm among all polymorphism and T786C-TT (29.3%) had the lowest number of vasospasm though all individual polymorphism were not statistically significant with the outcome [Figure 4]. Seven cases had multiple aneurysms and most common polymorphisms were 4BB (71%) (24-VNTR), TT (71%) (T-786-C), and GG (57%) (G894T).
Figure 4: Incidence of vasospasm in different variety of eNOS polymorphism. G894T-TT polymorphism patients had the highest number of vasospasm

Click here to view


Follow-up was available for 95 patients and 5 patients expired (2 in hospital and 3 during follow-up). The median follow-up was 8 months (6-50 months). The mean GOS at discharge and follow-up (6 months) were 3.86,4.24.

Association of eNOS gene polymorphism and outcome

Results of the univariate analysis of patient related factors [Table 3] showed smoking was significantly associated with unfavorable outcome (OR: 3.19, CI: 1.19–8.84, P = 0.01). However, age, sex, preoperative hypertension, and diabetes were not associated with an unfavorable outcome. AA (OR: 12.15, CI: 1.13–624.9, P = 0.03) variety of 24-VNTR polymorphism and CC (OR: 15.39, CI: 1.60–762.8, P = 0.01) variety of T786C polymorphism were influencing the 6 month poor functional outcome in univariate analysis.
Table 3: Analysis of predictors (patients related) for unfavorable predictors

Click here to view


Among the aneurysm-related factors [Table 4], Fisher grade 4 (OR: 3.43, CI: 1.24–9.68, P = 0.01), WFNS grade (poor vs. good) (OR: 3.42, CI: 1.17–10.12, P = 0.02), Vasospasm (OR: 3.84, CI: 1.42–10.75, P = 0.006), and intraoperative rupture (OR: 4.77, CI: 1.55–15.27, P = 0.004) were strong predictors of an unfavorable functional outcome. The regression analysis revealed [Table 5] smoking (CI: 0.06–0.69, P = 0.01), Fisher grade 4 (CI: 0.09–1.00, P = 0.05) and intaroperative rupture (CI: 0.05–0.89, P = 0.03) were related with with a six month unfavorable outcome. Individual polymorphism incidence in relation to WFNS grade, Fisher grade, and type of circulation, and an unfavorable outcome was mentioned in table [Table 6].
Table 4: Analysis of predictors (aneurysm related) for unfavorable predictors

Click here to view
Table 5: Regression analysis of predictors of unfavorable outcome

Click here to view
Table 6: Relationship of individual polymorphism with WFNS grade Fisher grade, type of circulation and unfavorable outcome

Click here to view



 » Discussion Top


Endothelial nitric oxide synthases (eNOS) expressed in endothelial cells play a major role in shear-stress response related endothelial dysfunction, which has been recognized as the underlying pathological processes of intracranial aneurysms.[7] The eNOS polymorphism is correlated with the size of an aneurysm,[1],[8] the risk for rupture,[9] and the risk for aneurysm formation.[5],[10],[11] However, literature is sparse regarding the correlation between eNOS and functional outcome. The present cohort attempts to analyze the correlation of the genetic (eNOS gene polymorphism) and as morphological risk factors associated with an unfavorable outcome after aSAH.

eNOS polymorphism and SAH

The eNOS T-786C SNP [12] is one of the most frequently investigated mutations associated with a cerebral aneurysm because it is located in the eNOS promoter region, which potentially affects eNOS expression. Mutations in other areas like intron-4 27-bp VNTR,[13] the exon-7 G894T SNPs [10] also affect the expression of eNOS gene and increase risk for a cerebral aneurysm. Khurana et al.[5] had reported that the eNOS 27 VNTR (in particular, the “4a” allele) is significantly associated (P = 0.007) with the occurrence of aneurysmal SAH and that the eNOS T-786C SNP (in particular, the “C” allele) is significantly associated with the occurrence of post-SAH vasospasm. Alexander et al.[14] showed that a combination of variant alleles of all three SNP of eNOS was associated with cerebral vasospasm. Our study showed that the homozygous variety, 4BB genotype (65%), TT (71%) of T-786C, and GG (71%) of the G894T polymorphism was most common haplotype frequency in the aneurysmal group. The allelic frequency in controls and patients population was following the Hardy–Weinberg equilibrium. As there was no association between the eNOS gene variants and aSAH in our population, the distribution of the genotypes did not differ much between cases and controls. The various environmental factors and ethnic background, played a major role in aneurysm formation but in our population, the association is lacking.

Risk factors and outcome

The outcome of aSAH correlates with patient associated factors as well as the severity of SAH. A recent meta-analysis [15] of epidemiological studies suggested that smoking (OR, 3.1; 95% CI, 2.7–3.5), hypertension (OR, 2.6; 95% CI, 2.0–3.1), and excessive alcohol intake (OR, 1.5; 95% CI, 1.3–1.8) are major risk factors of aSAH whereas diabetes was associated with a reduced risk of aSAH (OR, 0.7; 95% CI, 0.5–0.8). In the SAHIT study,[16] hypertension contribute to an inferior outcome at 3 months follow-up after SAH. Female gender was associated with poor outcome.[17],[18] However, other studies reported no influence of female gender with outcome.[19] McGirt et al.[20] found older age and hypertension was associated with a poor outcome after SAH in univariate as well as multivariate analysis. WFNS grades 4, 5, and shorter hospital stay was closely related with poor outcome.[19] Rosengart et al.,[21] reported in their study that various factors like age, poor neurological grade, high fisher grade, hypertension, intraventricular hemorrhage, intracerebral hemorrhage were associated with unfavorable outcome. Koshy et al.[22] did a study in a similar population and found that hypertension and smoking were related to aSAH but unrelated to the eNOS polymorphism. The International cooperative study [17] also reported the similar predictive factors for poor outcome. In another study,[23] only age (>60 years), and hydrocephalus were the predictors of poor functional outcome. However, Fisher grade, aneurysm size, intraoperative rupture, vasospasm were not related to poor outcome. The location of aneurysms, size, intraoperative rupture, and vasospasm are closely correlated with patient outcome after aSAH. Hamdan et al.[19] found that internal carotid artery aneurysm (P = 0.01) and posterior circulation (P = 0.006) location were related with poor outcome regression analysis. Posterior circulation aneurysm (P = 0.0001) and larger aneurysm size (P = 0.001) were associated with an unfavorable outcome.[21] In our cohort, hypertension, smoking, Fisher grade 4, intraoperative rupture, and vasospasm were closely related with a poor outcome in univariate as well as regression analysis after treatment of aSAH.

Genetic polymorphism and functional outcome after subarachnoid hemorrhage

Various genes [5],[24],[25],[26],[27],[28],[29] (eNOS, Endothelin, RAS, Apo e, Epoxide hydrolase, BDNF) were analyzed related to functional outcome after aSAH. Alexander et al.[14] found that a single copy of the variant allelles of SNP (rs1799983) of the eNOS gene (P < 0.001), was associated with a poorer outcome at 6 months GOS follow-up. Song et al.[30] found a relationship between T-786 C polymorphism and unfavorable outcome (CI: 1.131–16.108, P = 0.032). The polymorphism associated with high degrees of vasospasm is indirectly related with poor outcome at follow-up. Stark et al.,[31] reported T allele of T-786-C is strongly related to severe vasospasm. Hendrix et al.,[32] found C allele of T-786-C is related to delayed cerebral ischemia in univariate analysis. But in regression analysis, the same factor is not related with the final functional outcome. Our cohort showed that the AA of 24-VNTR polymorphism and CC of T-786C polymorphism was associated with an unfavorable outcome at the six month follow-up in univariate analysis. However, this was not significant in regression analysis.

Few other genes are correlated with functional outcome after aSAH. The gene polymorphism,[28] and the T allele of the END1 T/G SNP (rs1800541) were associated with aSAH but not correlated with the functional outcome. The Renin system polymorphism [27] (ACE I/D) was analyzed with aSAH and the recessive effect of allele I (insertion) (OR: 2.76, 95% CI: 1.17–6.50; P = 0.0206) was correlated with an unfavorable outcome. The K genotype group of soluble epoxide hydrolase [26] was correlated with a poor functional outcome. Apolipoprotein E ε2 or ε4–genotypes of APO E gene polymorphism were not related to inferior outcome.[24] The allele of brain-derived neurotropic factor (BDNF) was associated with a poor outcome.[25] In the near future, the genetic parameter also should be included as a predictive marker for prognostication.

Limitations

Our study sample demonstrates the trend toward the outcome. A larger sample may perhaps show conclusively. The other factors that may have an association are the duration of hypertension, the amount, and duration of smoking as well as the time of collection of the blood sample for genetic analysis. The present study included the generic parameters, non-modifiable factors, and aneurysmal factors for analysis of functional outcome after treatment.


 » Conclusion Top


In this case-control study, we have explored the hypothesis of whether polymorphisms in the eNOS gene are associated with aSAH in Indian population. In our study, smoking, clinical grade (WFNS), Fisher grade 4, intraoperative rupture of an aneurysm, 4AA of 24-VNTR, CC of T-786C polymorphism, and vasospasm had an impact on the six month outcom. A larger multicenter study may perhaps give a more definite answer whether the above predictive factors are useful in the prognostication of aSAH.

Disclosure

Indian Council of Medical Research (ICMR) Grants.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
 » References Top

1.
Akagawa H, Kasuya H, Onda H, Yoneyama T, Sasahara A, Kim CJ, et al. Influence of endothelial nitric oxide synthase T-786C single nucleotide polymorphism on aneurysm size. J Neurosurg 2005;102:68-71.  Back to cited text no. 1
    
2.
Paschoal EH, Yamaki VN, Teixeira RK, Paschoal Junior FM, Jong-A-Liem GS, Teixeira MJ, et al. Relationship between endothelial nitric oxide synthase (eNOS) and natural history of intracranial aneurysms: A meta-analysis. Neurosurg Rev 2018;41:87-94.  Back to cited text no. 2
    
3.
Rosalind Lai PM, Du R. Role of genetic polymorphisms in predicting delayed cerebral ischemia and radiographic vasospasm after aneurysmal subarachnoid hemorrhage: A meta-analysis. World Neurosurg 2015;84:933-41 e2.  Back to cited text no. 3
    
4.
Ducruet AF, Gigante PR, Hickman ZL, Zacharia BE, Arias EJ, Grobelny BT, et al. Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 2010;30:676-88.  Back to cited text no. 4
    
5.
Khurana VG, Sohni YR, Mangrum WI, McClelland RL, O'Kane DJ, Meyer FB, et al. Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm. J Cereb Blood Flow Metab 2004;24:291-7.  Back to cited text no. 5
    
6.
Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J, et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997;17:3147-53.  Back to cited text no. 6
    
7.
Dosenko VE, Zagoriy VY, Haytovich NV, Gordok OA, Moibenko AA. Allelic polymorphism of endothelial NO-synthase gene and its functional manifestations. Acta Biochim Pol 2006;53:299-302.  Back to cited text no. 7
    
8.
Khurana VG, Sohni YR, Mangrum WI, McClelland RL, O'Kane DJ, Meyer FB, et al. Endothelial nitric oxide synthase T-786C single nucleotide polymorphism: A putative genetic marker differentiating small versus large ruptured intracranial aneurysms. Stroke 2003;34:2555-9.  Back to cited text no. 8
    
9.
Khurana VG, Meissner I, Sohni YR, Bamlet WR, McClelland RL, Cunningham JM, et al. The presence of tandem endothelial nitric oxide synthase gene polymorphisms identifying brain aneurysms more prone to rupture. J Neurosurg 2005;102:526-31.  Back to cited text no. 9
    
10.
Ozüm U, Bolat N, Gül E, Ozdemir O. Endothelial nitric oxide synthase gene [G894T] polymorphism as a possible risk factor for aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 2008;150:57-61; discussion 62.  Back to cited text no. 10
    
11.
Kim TG, Kim NK, Baek MJ, Huh R, Chung SS, Choi JU, et al. The relationships between endothelial nitric oxide synthase polymorphisms and the formation of intracranial aneurysms in the Korean population. Neurosurg Focus 2011;30:E23.  Back to cited text no. 11
    
12.
Ko NU, Rajendran P, Kim H, Rutkowski M, Pawlikowska L, Kwok PY, et al. Endothelial nitric oxide synthase polymorphism (-786T->C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2008;39:1103-8.  Back to cited text no. 12
    
13.
Staalsø JM, Edsen T, Kotinis A, Romner B, Springborg JB, Olsen NV. Association of the NOS3 intron-4 VNTR polymorphism with aneurysmal subarachnoid hemorrhage. J Neurosurg 2014;121:587-92.  Back to cited text no. 13
    
14.
Alexander SA, Poloyac SM, Hoffman L, Gallek M, Ren D, Balzer J, et al. Endothelial nitric oxide synthase tagging single nucleotide polymorphisms and recovery from aneurysmal subarachnoid hemorrhage. Biol Res Nurs 2009;11:42-52.  Back to cited text no. 14
    
15.
Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, van Gijn J, et al. Risk factors for subarachnoid hemorrhage: An updated systematic review of epidemiological studies. Stroke 2005;36:2773-80.  Back to cited text no. 15
    
16.
Jaja BN, Lingsma H, Schweizer TA, Thorpe KE, Steyerberg EW, Macdonald RL, et al. Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: Pooled analyses of individual patient data in the SAHIT repository. J Neurosurg 2015;122:644-52.  Back to cited text no. 16
    
17.
Kassell NF, Torner JC, Haley Jr EC, Jane JA, Adams HP, Kongable GL, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990;73:18-36.  Back to cited text no. 17
    
18.
Rosenłrn J, Eskesen V, Schmidt K. Clinical features and outcome in females and males with ruptured intracranial saccular aneurysms. Br J Neurosurg 1993;7:287-90.  Back to cited text no. 18
    
19.
Hamdan A, Barnes J, Mitchell P. Subarachnoid hemorrhage and the female sex: Analysis of risk factors, aneurysm characteristics, and outcomes. J Neurosurg 2014;121:1367-73.  Back to cited text no. 19
    
20.
McGirt MJ, Woodworth GF, Ali M, Than KD, Tamargo RJ, Clatterbuck RE. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 2007;107:1080-5.  Back to cited text no. 20
    
21.
Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2315-21.  Back to cited text no. 21
    
22.
Koshy L, Easwer HV, Neetha NV, Natarajan C, Bhattacharya RN, Banerjee M. Role of endothelial nitric oxide synthase gene polymorphisms in predicting aneurysmal subarachnoid hemorrhage in South Indian patients. Dis Markers 2008;24:333-9.  Back to cited text no. 22
    
23.
Beneš V Rd, Jurák L, Brabec R, Nechanická N, Šercl M, Endrych L, et al. Causes of poor outcome in patients admitted with good-grade subarachnoid hemorrhage. Acta Neurochir (Wien) 2017;159:559-65.  Back to cited text no. 23
    
24.
Juvela S, Siironen J, Lappalainen J. Apolipoprotein E genotype and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 2009;110:989-95.  Back to cited text no. 24
    
25.
Vilkki J, Lappalainen J, Juvela S, Kanarek K, Hernesniemi JA, Siironen J. Relationship of the Met allele of the brain-derived neurotrophic factor Val66Met polymorphism to memory after aneurysmal subarachnoid hemorrhage. Neurosurgery 2008;63:198-203; discussion 203.  Back to cited text no. 25
    
26.
Martini RP, Ward J, Siler DA, Eastman JM, Nelson JW, Borkar RN, et al. Genetic variation in soluble epoxide hydrolase: Association with outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 2014;121:1359-66.  Back to cited text no. 26
    
27.
Griessenauer CJ, Tubbs RS, Foreman PM, Chua MH, Vyas NA, Lipsky RH, et al. Association of renin-angiotensin system genetic polymorphisms and aneurysmal subarachnoid hemorrhage. J Neurosurg 2018;128:86-93.  Back to cited text no. 27
    
28.
Griessenauer CJ, Starke RM, Foreman PM, Hendrix P, Harrigan MR, Fisher WS 3rd, et al. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome. J Neurosurg 2017 [Epub ahead of print].  Back to cited text no. 28
    
29.
Dhandapani S, Goudihalli S, Mukherjee KK, Singh H, Srinivasan A, Danish M, et al. Prospective study of the correlation between admission plasma homocysteine levels and neurological outcome following subarachnoid hemorrhage: A case for the reverse epidemiology paradox? Acta Neurochir (Wien) 2015;157:399-407.  Back to cited text no. 29
    
30.
Song MK, Kim MK, Kim TS, Joo SP, Park MS, Kim BC, et al. Endothelial nitric oxide gene T-786C polymorphism and subarachnoid hemorrhage in Korean population. J Korean Med Sci 2006;21:922-6.  Back to cited text no. 30
    
31.
Starke RM, Kim GH, Komotar RJ, Hickman ZL, Black EM, Rosales MB, et al. Endothelial nitric oxide synthase gene single-nucleotide polymorphism predicts cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 2008;28:1204-11.  Back to cited text no. 31
    
32.
Hendrix P, Foreman PM, Harrigan MR, Fisher WS 3rd, Vyas NA, Lipsky RH, et al. Endothelial nitric oxide synthase polymorphism is associated with delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage. World Neurosurg 2017;101:514-9.  Back to cited text no. 32
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow